...
首页> 外文期刊>Journal of drugs in dermatology: JDD >Novel Skin Brightener Used as Monotherapy for Moderate Melasma in Skin of Color
【24h】

Novel Skin Brightener Used as Monotherapy for Moderate Melasma in Skin of Color

机译:新型皮肤增白剂用作有色皮肤中度黄褐斑的单一疗法

获取原文
获取原文并翻译 | 示例
           

摘要

Melasma is a chronic, relapsing disorder that can be disfiguring and can have adverse effects on quality of life. Recently, a unique hydroquinone-free topical product addressing multiple pathways involved in pigmentation was shown to have similar efficacy and equally well tolerated as 4% hydroquinone in females with facial hyperpigmentation. The goal herein was to further assess the efficacy and tolerability of this new multimodality product for the control of moderate melasma in skin of color.
机译:黄褐斑是一种慢性复发性疾病,可能会毁容容貌,并对生活质量产生不利影响。最近,一种独特的不含氢醌的局部产品解决了涉及色素沉着的多种途径,被证明具有相似的功效,并且在面部色素沉着过度的女性中耐受性与4%的氢醌相同。本文的目的是进一步评估这种新的多模态产品用于控制有色皮肤中的黄褐斑的功效和耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号